RankingsPricing
  1. US-listed companies
  2. Merck & Co., Inc.
  3. Financials
  4. Cash from investing

Merck & Co., Inc.MRK

Market cap
$251.9B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-7,734-45.08%
Dec 31, 2023-14,083+183.93%
Dec 31, 2022-4,960-69.79%
Dec 31, 2021-16,421+73.90%
Dec 31, 2020-9,443+259.19%
Dec 31, 2019-2,629-160.94%
Dec 31, 20184,314+61.03%
Dec 31, 20172,679-183.46%
Dec 31, 2016-3,210-32.53%
Dec 31, 2015-4,758+1172.19%
Dec 31, 2014-374-88.12%
Dec 31, 2013-3,148-53.74%
Dec 31, 2012-6,805+135.47%
Dec 31, 2011-2,890-17.36%
Dec 31, 2010-3,497

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)